Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/?or Scalp Psoriasis (VISIBLE)
Research payments
$1,040,470
Through program year 2025, $1,040,470 in research payments was reported against Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/?or Scalp Psoriasis (VISIBLE), across 272 payments, paid by Janssen Research & Development, LLC.
- Paid by
- Janssen Research & Development, LLC
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,040,470 | 272 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Eduardo Weiss Hollywood, FL Named on 18 payments
- Jorge Garcia Zuazaga Concord Township, OH Named on 12 payments
- Angela Moore Arlington, TX Named on 12 payments
- Jun Lu Farmington, CT Named on 11 payments
- Mark Lee San Antonio, TX Named on 10 payments
- Gregory Simpson Fresno, CA Named on 10 payments
- Joel Joyce Skokie, IL Named on 9 payments
- Mark Amster Brighton, MA Named on 9 payments
- Tory Sullivan North Miami Beach, FL Named on 9 payments
- Ann Reed Boca Raton, FL Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.